Complete Filing Data
Royalty Pharma plc reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $9.71 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Royalty Pharma plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income * | $770.9M | $859.0M | $1.13B | $42.8M | $619.7M | $975.0M | $2.35B | $1.38B |
| Revenues | $2.38B | $2.26B | $2.35B | $2.24B | $2.29B | $2.12B | $1.81B | $1.79B |
| Research And Development Expense | $452.0M | $2.0M | $52.0M | $177.1M | $200.1M | $26.3M | $83.0M | $392.6M |
| Other Nonoperating Income Expense | -$14.3M | -$1.5M | -$21.7M | -$14.8M | -$5.7M | -$32.8M | $393.0K | -$1.5M |
| Operating Income Loss | $1.56B | $1.29B | $1.49B | $307.1M | $1.43B | $1.60B | $2.62B | $1.36B |
| Nonoperating Income Expense | -$235.3M | $38.4M | $207.9M | -$77.0M | -$189.5M | $106.6M | -$161.8M | $153.4M |
| Net Income Loss Attributable To Noncontrolling Interest | $553.2M | $471.8M | $565.3M | $187.2M | $621.5M | $726.9M | $112.9M | $140.1M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Equity Method Investments | $29.1M | $29.6M | $28.9M | -$9.0M | -$19.5M | $44.5M | -$32.5M | -$7.0M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $1.32B | $1.33B | $1.70B | $230.1M | $1.24B | $1.70B | $2.46B | $1.52B |
| General And Administrative Expense | $573.5M | $236.7M | $249.7M | $227.3M | $182.8M | $181.7M | $103.4M | $61.9M |
| Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | -$29.4M | -$39.3M | $66.6M | $12.3M | -$394.5M | |
| Comprehensive Income Net Of Tax | $859.0M | $1.13B | $25.2M | $597.6M | $1.03B | $2.36B | $983.2M | |
| Amortization Of Intangible Assets | $0.00 | $0.00 | $5.7M | $23.0M | $23.1M | $23.9M | $33.3M | |
| Interest Expense | $187.2M | $188.0M | $166.1M | $157.1M | $268.6M | $280.0M | ||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.33B | $1.70B | $200.6M | $1.20B | $1.77B | $2.47B | $983.2M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $24.0M | $11.6M | $83.1M | $6.2M | -$402.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $288.2M | $30.2M | $238.3M | $544.0M | $102.0M | $4.8M | $72.1M | $227.6M | $340.8M | $142.7M | $304.5M | $51.8M | $101.9M | $440.8M | $69.1M | $290.6M | $442.1M | $71.2M | $409.0M | $151.7M |
| Revenues | $609.3M | $578.7M | $568.2M | $564.7M | $537.3M | $568.0M | $536.3M | $538.2M | $684.0M | $573.5M | $536.0M | $562.0M | $585.8M | $555.0M | $573.0M | $538.4M | $510.9M | $500.9M | $464.3M | $457.6M |
| Research And Development Expense | $50.5M | $300.5M | $50.5M | $500.0K | $500.0K | $500.0K | $50.5M | $500.0K | $500.0K | $25.5M | $606.0K | $100.5M | $90.5M | $3.1M | $2.6M | $5.1M | $5.8M | $7.6M | $22.7M | $21.5M |
| Other Nonoperating Income Expense | -$1.6M | -$1.5M | -$3.1M | -$1.7M | $6.0M | -$3.7M | -$1.7M | $1.1M | -$2.8M | -$10.8M | -$1.0M | -$1.8M | -$793.0K | -$107.0K | $43.0K | -$23.3M | $261.0K | -$5.9M | $232.0K | -$37.0K |
| Operating Income Loss | $427.2M | $209.8M | $534.2M | $735.1M | $269.6M | -$73.8M | $151.4M | $248.8M | $479.0M | $192.2M | $377.8M | $219.7M | $303.1M | $744.9M | $229.3M | $510.6M | $409.3M | $361.4M | $532.5M | $327.9M |
| Nonoperating Income Expense | $17.1M | -$119.2M | -$100.7M | $71.3M | -$75.3M | $69.5M | -$29.4M | $102.5M | $30.1M | $28.2M | $113.8M | -$91.6M | -$81.3M | $61.8M | -$70.3M | $113.7M | $192.6M | -$252.3M | -$92.5M | -$149.1M |
| Net Income Loss Attributable To Noncontrolling Interest | $156.0M | $60.5M | $195.1M | $262.4M | $92.4M | -$9.1M | $50.0M | $123.7M | $168.3M | $77.8M | $187.1M | $76.3M | $119.9M | $366.0M | $89.9M | $333.6M | $159.9M | $37.9M | $31.0M | $27.1M |
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Loss From Equity Method Investments | $15.9M | $2.7M | $6.4M | $10.4M | $1.7M | -$14.1M | -$5.2M | -$770.0K | $34.6M | -$3.3M | $737.0K | $397.0K | $2.7M | $17.7M | -$1.9M | $13.7M | $29.3M | -$9.1M | -$8.0M | -$8.1M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $444.2M | $90.6M | $433.4M | $806.4M | $194.4M | -$4.3M | $122.1M | $351.3M | $509.1M | $220.4M | $491.6M | $128.1M | $221.8M | $806.8M | $159.0M | $624.3M | $602.0M | $109.1M | $440.0M | $178.8M |
| General And Administrative Expense | $118.7M | $179.8M | $110.7M | $56.7M | $54.7M | $57.7M | $57.2M | $47.6M | $85.7M | $50.7M | $51.8M | $51.5M | $48.6M | $44.9M | $43.2M | $50.7M | $42.8M | $38.1M | $25.6M | $30.3M |
| Other Comprehensive Income Loss Net Of Tax | $0.00 | $0.00 | $0.00 | $5.9M | $1.3M | -$7.3M | -$14.3M | -$7.3M | -$10.4M | $7.6M | $6.9M | $56.8M | -$1.3M | $4.5M | ||||||
| Comprehensive Income Net Of Tax | $72.1M | $227.6M | $340.8M | $146.2M | $305.3M | $47.4M | $93.6M | $436.7M | $63.6M | $294.4M | $447.4M | $118.4M | $407.7M | $156.3M | ||||||
| Amortization Of Intangible Assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $5.7M | $5.8M | $5.7M | $5.7M | $5.8M | $5.7M | $5.7M | $5.8M | $5.7M | ||||||
| Interest Expense | $44.2M | $46.0M | $46.9M | $47.0M | $47.0M | $47.0M | $47.1M | $44.3M | $37.4M | $37.4M | $31.4M | $34.2M | $53.6M | $68.8M | $69.2M | |||||
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $122.1M | $351.3M | $509.1M | $226.4M | $492.9M | $120.8M | $207.5M | $799.5M | $148.6M | $298.2M | $449.0M | $128.0M | $407.7M | $156.3M | ||||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $0.00 | $0.00 | $0.00 | $13.1M | $9.3M | $1.6M | -$2.6M | $6.0M | $5.1M | $7.6M | $6.9M | $52.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | $9.71B | $10.34B | $10.08B | $9.53B | $10.25B | $9.90B | $6.14B | $4.55B | $4.46B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $618.7M | $929.0M | $477.0M | $1.71B | $1.54B | $1.01B | $246.2M | $1.92B | $1.38B |
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $541.3M | $476.6M | $487.7M | $604.2M | $615.0M | $1.11B | $880.1M | $1.03B | |
| Equity Securities Fv Ni Unrealized Gain Loss | -$21.9M | $39.5M | $87.1M | -$33.4M | -$48.1M | $247.1M | $155.7M | -$13.9M | |
| Debt Securities Available For Sale Unrealized Gain Loss | $45.9M | $154.9M | $230.8M | -$6.8M | $17.9M | $18.6M | $0.00 | ||
| Dividends Cash | $378.3M | $376.5M | $358.3M | $333.3M | $285.2M | $112.5M | |||
| Stockholders Equity Other | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$191.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$310.3M | $452.0M | -$1.23B | $169.7M | $532.4M | $762.5M | -$1.68B | $542.6M | |
| Equity Method Investment Dividends Or Distributions | $13.4M | $13.4M | $18.8M | $39.1M | $34.4M | $42.3M | $14.1M | $39.4M | |
| Retained Earnings Accumulated Deficit | $2.36B | $2.85B | $2.52B | $1.96B | $2.26B | $1.92B | $2.83B | ||
| Other Royalty Income Receivable Current | $29.3M | $27.0M | $22.4M | $19.8M | $15.0M | $6.0M | $5.2M | ||
| Other Assets Current | $6.9M | $4.2M | $18.0M | $90.5M | $6.6M | $8.6M | $92.0K | ||
| Notes And Loans Receivable Net Noncurrent | $16.21B | $15.13B | $14.09B | $13.49B | $13.72B | $12.37B | $10.84B | ||
| Notes And Loans Receivable Net Current | $854.4M | $783.8M | $738.4M | $691.3M | $614.4M | $587.2M | $452.6M | ||
| Minority Interest | $3.24B | $3.40B | $3.56B | $3.90B | $4.47B | $5.08B | $35.9M | ||
| Long Term Debt Noncurrent | $8.57B | $6.61B | $6.14B | $6.12B | $7.10B | $5.82B | $5.96B | ||
| Liabilities Current | $636.2M | $1.25B | $161.4M | $1.17B | $171.3M | $307.9M | $333.4M | ||
| Liabilities And Stockholders Equity | $19.62B | $18.22B | $16.38B | $16.81B | $17.52B | $16.02B | $12.45B | ||
| Liabilities | $9.91B | $7.88B | $6.30B | $7.29B | $7.27B | $6.12B | $6.31B | ||
| Equity Method Investments | $290.0M | $379.4M | $375.9M | $397.2M | $435.4M | $454.9M | $124.1M | ||
| Cash And Cash Equivalents At Carrying Value | $618.7M | $929.0M | $477.0M | $1.71B | $1.54B | $1.01B | $246.2M | ||
| Assets Current | $1.53B | $1.80B | $1.27B | $2.55B | $2.88B | $2.70B | $832.1M | ||
| Assets | $19.62B | $18.22B | $16.38B | $16.81B | $17.52B | $16.02B | $12.45B | ||
| Accounts Payable And Accrued Liabilities Current | $19.4M | $13.4M | $15.2M | $7.9M | $5.6M | $10.8M | $11.2M | ||
| Other Assets Noncurrent | $79.3M | $33.5M | $6.5M | $29.6M | $4.1M | $10.0M | $45.6M | ||
| Deferred Shares Value Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Available For Sale Securities Debt Securities Noncurrent | $419.0M | $693.5M | $437.1M | $226.3M | $204.4M | $163.0M | $131.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | $9.62B | $9.50B | $9.79B | $10.26B | $9.75B | $9.86B | $9.59B | $9.81B | $9.82B | $10.42B | $10.41B | $10.14B | $10.39B | $10.41B | $9.84B | $9.80B | $9.39B | $7.16B | $4.90B | $4.65B | $4.71B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $938.9M | $631.9M | $1.09B | $950.1M | $1.76B | $843.0M | $936.4M | $2.17B | $1.98B | $991.6M | $2.11B | $1.79B | $1.80B | $1.14B | $708.8M | $1.55B | $2.32B | $498.1M | $116.4M | $593.3M | |
| Minority Interest Decrease From Distributions To Noncontrolling Interest Holders | $116.0M | $136.9M | $171.4M | $113.2M | $129.7M | $124.4M | $120.2M | $137.3M | $129.1M | $137.9M | $147.0M | $149.0M | $159.7M | $170.8M | $145.4M | $175.3M | $296.5M | $393.2M | $196.7M | $233.5M | |
| Equity Securities Fv Ni Unrealized Gain Loss | $18.9M | -$30.6M | -$45.9M | $50.8M | -$47.1M | $77.7M | $1.5M | $41.3M | -$10.8M | $5.2M | $8.0M | -$36.2M | -$19.3M | $55.5M | -$54.2M | $160.2M | $193.9M | -$153.2M | -$6.9M | -$36.8M | |
| Debt Securities Available For Sale Unrealized Gain Loss | $52.5M | -$27.4M | -$3.3M | $57.7M | -$200.0K | $46.4M | $7.3M | $82.9M | $32.3M | $44.2M | $70.3M | -$16.6M | -$14.9M | $14.0M | $9.1M | $0.00 | $0.00 | $0.00 | |||
| Dividends Cash | $95.3M | $93.3M | $95.4M | $94.1M | $94.9M | $93.8M | $89.8M | $90.6M | $88.6M | $83.8M | $83.0M | $82.3M | $73.0M | $72.6M | $66.0M | $54.9M | |||||
| Stockholders Equity Other | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $158.7M | $366.0M | $264.9M | $250.5M | -$299.9M | $251.9M | |||||||||||||||
| Equity Method Investment Dividends Or Distributions | $13.4M | $13.4M | $16.3M | $20.7M | $17.3M | $20.3M | |||||||||||||||
| Retained Earnings Accumulated Deficit | $2.30B | $2.22B | $2.48B | $2.76B | $2.38B | $2.43B | $2.13B | $2.25B | $2.22B | $2.50B | $2.45B | $2.22B | $2.32B | $2.29B | $1.92B | $1.81B | $1.57B | ||||
| Other Royalty Income Receivable Current | $28.9M | $27.7M | $23.8M | $24.9M | $23.6M | $22.2M | $21.6M | $18.9M | $22.1M | $19.1M | $17.3M | $14.6M | $13.8M | $10.7M | $6.5M | $4.4M | $3.1M | ||||
| Other Assets Current | $5.5M | $4.5M | $3.1M | $5.0M | $2.3M | $5.0M | $6.8M | $10.2M | $4.6M | $90.5M | $67.1M | $5.4M | $8.9M | $12.1M | $6.7M | $14.4M | $12.8M | ||||
| Notes And Loans Receivable Net Noncurrent | $15.76B | $15.13B | $15.03B | $14.97B | $13.89B | $13.47B | $13.23B | $13.27B | $13.66B | $14.29B | $13.42B | $13.47B | $14.01B | $12.93B | $12.60B | $11.93B | $11.17B | ||||
| Notes And Loans Receivable Net Current | $860.1M | $842.9M | $716.6M | $765.8M | $750.1M | $660.5M | $742.2M | $729.9M | $610.0M | $675.9M | $639.2M | $570.7M | $579.7M | $596.9M | $522.4M | $556.9M | $526.9M | ||||
| Minority Interest | $3.21B | $3.16B | $3.10B | $3.39B | $3.28B | $3.36B | $3.45B | $3.53B | $3.87B | $4.26B | $4.38B | $4.36B | $4.59B | $4.67B | $4.95B | $5.35B | $5.24B | ||||
| Long Term Debt Noncurrent | $8.57B | $7.00B | $6.62B | $6.61B | $7.60B | $6.14B | $6.13B | $6.13B | $6.12B | $6.11B | $7.11B | $7.10B | $7.09B | $5.83B | $5.82B | $5.81B | $5.73B | ||||
| Liabilities Current | $530.8M | $1.21B | $1.18B | $1.17B | $275.7M | $124.6M | $127.9M | $1.17B | $1.12B | $1.13B | $182.3M | $135.9M | $255.1M | $284.0M | $256.0M | $270.0M | $451.0M | ||||
| Liabilities And Stockholders Equity | $19.35B | $18.32B | $17.61B | $18.04B | $17.66B | $16.13B | $15.86B | $17.12B | $17.07B | $17.67B | $17.74B | $17.38B | $17.73B | $16.51B | $15.91B | $15.99B | $15.69B | ||||
| Liabilities | $9.73B | $8.82B | $7.82B | $7.78B | $7.90B | $6.27B | $6.27B | $7.31B | $7.25B | $7.26B | $7.33B | $7.24B | $7.35B | $6.11B | $6.08B | $6.19B | $6.29B | ||||
| Equity Method Investments | $291.0M | $275.9M | $336.2M | $351.0M | $352.1M | $350.4M | $378.3M | $384.3M | $384.3M | $409.9M | $412.1M | $418.2M | $473.1M | $465.6M | $444.4M | $439.8M | $430.3M | ||||
| Cash And Cash Equivalents At Carrying Value | $938.9M | $631.9M | $1.09B | $950.1M | $1.76B | $843.0M | $936.4M | $2.17B | $1.98B | $991.6M | $2.11B | $1.79B | $1.80B | $1.14B | $708.8M | $1.55B | $2.44B | ||||
| Assets Current | $1.85B | $1.52B | $1.84B | $1.79B | $2.58B | $1.56B | $1.73B | $2.95B | $2.63B | $2.34B | $3.50B | $2.98B | $2.78B | $2.71B | $2.42B | $2.78B | $3.39B | ||||
| Assets | $19.35B | $18.32B | $17.61B | $18.04B | $17.66B | $16.13B | $15.86B | $17.12B | $17.07B | $17.67B | $17.74B | $17.38B | $17.73B | $16.51B | $15.91B | $15.99B | $15.69B | ||||
| Accounts Payable And Accrued Liabilities Current | $41.4M | $20.2M | $37.6M | $22.1M | $23.4M | $11.6M | $13.6M | $5.8M | $6.7M | $16.1M | $12.2M | $6.7M | $9.2M | $9.4M | $8.3M | $24.4M | $34.4M | ||||
| Other Assets Noncurrent | $86.6M | $85.5M | $36.7M | $42.8M | $27.6M | $4.5M | $20.2M | $29.4M | $28.0M | $30.6M | $33.4M | $3.9M | $4.5M | $6.0M | $4.3M | $4.9M | $0.00 | ||||
| Deferred Shares Value Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Available For Sale Securities Debt Securities Noncurrent | $302.5M | $271.9M | $219.0M | $657.3M | $629.9M | $473.7M | $353.6M | $343.7M | $267.2M | $339.8M | $63.0M | $239.6M | $188.7M | $202.5M | $179.9M | $155.0M | $162.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Proceeds From Interest Received | $34.3M | $46.5M | $71.6M | $25.0M | $3.1M | $7.7M | $20.1M | $24.4M |
| Proceeds From Cash Collections From Royalties Received On Intangible Assets | $720.0K | $14.6M | $1.3M | $72.9M | $151.2M | $143.8M | $143.3M | $106.7M |
| Proceeds From Cash Collections From Royalties Received On Financing Receivables | $3.35B | $2.98B | $3.20B | $2.51B | $2.32B | $2.12B | $1.93B | $2.05B |
| Proceeds From Cash Collections From Other Royalties Received On Financing Receivables | $114.0M | $108.8M | $158.8M | $69.9M | $44.1M | $18.3M | $27.4M | $125.2M |
| Payments To Minority Shareholders | $167.5M | $125.2M | $119.5M | $144.1M | $133.4M | $113.5M | $154.1M | $268.7M |
| Payments To Acquire Finance Receivables | $1.70B | $2.51B | $2.12B | $1.74B | $2.19B | $2.18B | $1.72B | $269.6M |
| Payments To Acquire Equity Method Investments | $0.00 | $11.0M | $12.5M | $9.9M | $34.9M | $40.2M | $27.0M | $24.2M |
| Payments For Operating Costs And Professional Services | $288.1M | $236.2M | $243.0M | $223.0M | $184.5M | $179.7M | $88.5M | $72.5M |
| Net Cash Provided By Used In Operating Activities | $2.49B | $2.77B | $2.99B | $2.14B | $2.02B | $2.03B | $1.67B | $1.62B |
| Net Cash Provided By Used In Investing Activities | -$1.61B | -$2.68B | -$2.07B | -$1.03B | -$1.87B | -$2.76B | -$2.15B | $303.4M |
| Net Cash Provided By Used In Financing Activities | -$1.19B | $361.1M | -$2.15B | -$944.9M | $385.1M | $1.49B | -$1.19B | -$1.38B |
| Stock Issued During Period Value Share Based Compensation | $2.3M | $2.4M | $2.2M | $2.4M | $5.4M | |||
| Proceeds From Sale Of Available For Sale Securities Debt | $21.2M | $19.8M | $1.4M | $542.0M | $62.5M | $3.0M | $150.0M | $750.0M |
| Proceeds From Noncontrolling Interests Research And Development | $220.0K | $747.0K | $543.0K | $1.1M | $7.3M | $8.5M | $0.00 | $0.00 |
| Proceeds From Noncontrolling Interests Other | $5.7M | $4.4M | $6.9M | $6.1M | $36.9M | $59.0M | $0.00 | $0.00 |
| Payments For Ongoing Development Stage Funding | $2.0M | $2.0M | $2.1M | $6.9M | $20.5M | $83.0M | $108.2M | |
| Payments To Acquire Available For Sale Securities Debt | $175.0M | $150.0M | $0.00 | $479.6M | $70.4M | $0.00 | $125.1M | $0.00 |
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $0.00 | $24.4M | $792.3M | $1.60B | $815.4M | $725.1M | $0.00 |
| Payments For Milestones | $271.3M | $75.0M | $12.4M | $0.00 | $18.6M | $0.00 | $250.0M | $0.00 |
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $105.1M | $23.6M | $43.9M | $0.00 | $523.0K | $15.1M | $0.00 | $0.00 |
| Payments To Acquire Equity Securities FNNI | $58.4M | $62.5M | $0.00 | $87.8M | $135.1M | $50.0M | $79.0M | $152.8M |
| Allocated Share Based Compensation Expense | $290.9M | $3.2M | $3.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Interest Received | $12.0M | $6.4M | $15.6M | $482.0K | $1.5M | $2.2M | ||||||||||||
| Proceeds From Cash Collections From Royalties Received On Intangible Assets | $177.0K | $13.5M | $617.0K | $35.7M | $35.8M | $34.8M | ||||||||||||
| Proceeds From Cash Collections From Royalties Received On Financing Receivables | $829.7M | $744.9M | $1.15B | $621.7M | $573.9M | $488.0M | ||||||||||||
| Proceeds From Cash Collections From Other Royalties Received On Financing Receivables | $31.8M | $26.3M | $19.7M | $17.3M | $6.8M | $535.0K | ||||||||||||
| Payments To Minority Shareholders | $53.8M | $32.0M | $33.4M | $34.5M | $125.7M | $161.4M | ||||||||||||
| Payments To Acquire Finance Receivables | $1.1M | $86.1M | $601.7M | $85.0K | $503.1M | $99.3M | ||||||||||||
| Payments To Acquire Equity Method Investments | $0.00 | $7.0M | $3.6M | $3.1M | $8.7M | $13.1M | ||||||||||||
| Payments For Operating Costs And Professional Services | $101.7M | $60.5M | $86.8M | $48.9M | $42.2M | $25.8M | ||||||||||||
| Net Cash Provided By Used In Operating Activities | $596.1M | $664.6M | $1.03B | $460.3M | $526.1M | $471.1M | ||||||||||||
| Net Cash Provided By Used In Investing Activities | $503.9M | -$86.7M | -$558.5M | $11.2M | -$599.3M | -$761.8M | ||||||||||||
| Net Cash Provided By Used In Financing Activities | -$941.3M | -$212.0M | -$210.4M | -$221.0M | -$226.7M | $542.5M | ||||||||||||
| Stock Issued During Period Value Share Based Compensation | $515.0K | $525.0K | $681.0K | $612.0K | $581.0K | $587.0K | $573.0K | $582.0K | $509.0K | $496.0K | $505.0K | $721.0K | $713.0K | $848.0K | $3.7M | |||
| Proceeds From Sale Of Available For Sale Securities Debt | $12.6M | $1.4M | $0.00 | $15.6M | $15.6M | $0.00 | ||||||||||||
| Proceeds From Noncontrolling Interests Research And Development | $220.0K | $88.0K | $279.0K | $624.0K | $2.0M | $1.3M | ||||||||||||
| Proceeds From Noncontrolling Interests Other | $1.1M | $1.3M | $3.3M | $1.6M | $220.0K | $29.8M | ||||||||||||
| Payments For Ongoing Development Stage Funding | $50.5M | $500.0K | $500.0K | $500.0K | $2.6M | $7.6M | ||||||||||||
| Payments To Acquire Available For Sale Securities Debt | $0.00 | $64.6M | $17.6M | $0.00 | $125.0M | |||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $0.00 | $24.4M | $274.6M | $419.8M | $104.6M | |||||||||||||
| Payments For Milestones | $50.0M | $0.00 | $12.4M | $0.00 | ||||||||||||||
| Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital | $36.3M | $5.0M | $34.8M | $0.00 | ||||||||||||||
| Payments To Acquire Equity Securities FNNI | $4.4M | $0.00 | $0.00 | $34.0M | $0.00 | $50.0M | ||||||||||||
| Allocated Share Based Compensation Expense | $73.4M | $713.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 429.8M | 448.2M | 447.6M | 438.0M | 414.8M | 375.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 564.5M | 594.1M | 602.9M | 438.0M | 414.8M | 375.5M | |
| Earnings Per Share Diluted | $1.78 | $1.91 | $2.53 | $0.10 | $1.49 | $1.32 | |
| Earnings Per Share Basic | $1.79 | $1.92 | $2.54 | $0.10 | $1.49 | $1.32 | |
| Common Stock Dividends Per Share Cash Paid | $0.84 | $0.80 | $0.76 | $0.68 | $0.30 | ||
| Deferred Shares Shares Outstanding | 411.5M | 392.3M | 384.6M | 371.3M | 361.2M | 316.4M | 0.00 |
| Deferred Shares Shares Issued | 411.5M | 392.3M | 384.6M | 371.3M | 361.2M | 316.4M | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 431.9M | 423.5M | 435.5M | 447.6M | 451.0M | 448.6M | 448.4M | 450.4M | 445.6M | 439.3M | 436.3M | 434.0M | 428.2M | 409.3M | 389.8M | 370.0M | 354.0M | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 559.6M | 562.3M | 578.1M | 592.7M | 596.9M | 597.5M | 601.1M | 605.9M | 607.3M | 607.2M | 607.2M | 607.2M | 607.2M | 607.2M | 607.1M | 370.0M | 354.0M | |||||
| Earnings Per Share Diluted | $0.67 | $0.07 | $0.55 | $1.21 | $0.23 | $0.01 | $0.16 | $0.50 | $0.76 | $0.32 | $0.70 | $0.12 | $0.24 | $1.08 | $0.18 | $0.79 | $0.09 | |||||
| Earnings Per Share Basic | $0.67 | $0.07 | $0.55 | $1.22 | $0.23 | $0.01 | $0.16 | $0.51 | $0.76 | $0.32 | $0.70 | $0.12 | $0.24 | $1.08 | $0.18 | $0.79 | $0.09 | |||||
| Common Stock Dividends Per Share Cash Paid | $0.22 | $0.22 | $0.22 | $0.22 | $0.21 | $0.21 | $0.21 | $0.21 | $0.20 | $0.20 | $0.20 | $0.20 | $0.19 | $0.19 | $0.19 | $0.19 | $0.17 | $0.17 | $0.17 | $0.17 | ||
| Deferred Shares Shares Outstanding | 409.9M | 409.0M | 394.5M | 390.5M | 390.1M | 388.9M | 382.8M | 382.5M | 376.4M | 369.3M | 365.3M | 363.5M | 357.7M | 355.2M | 321.1M | 298.3M | 294.2M | |||||
| Deferred Shares Shares Issued | 409.9M | 409.0M | 394.5M | 390.5M | 390.1M | 388.9M | 382.8M | 382.5M | 376.4M | 369.3M | 365.3M | 363.5M | 357.7M | 355.2M | 321.1M | 298.3M | 294.2M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Gain Loss On Derivative Instruments Net Pretax | $0.00 | -$6.0M | -$2.3M | $96.6M | -$21.5M | -$42.1M | -$39.1M | $11.9M |
| Costs And Expenses | $818.7M | $971.1M | $862.4M | $1.93B | $858.7M | $527.0M | -$808.9M | $430.4M |
| Noncontrolling Interest Increase From Contributions | $10.0M | $9.0M | $11.9M | $11.6M | $48.5M | $1.48B | ||
| Investment Income Net | $72.3M | $78.3M | $53.5M | $28.4M | $22.3M | $24.4M | ||
| Interest Paid Net | $276.3M | $159.6M | $169.2M | $170.1M | $130.4M | $103.2M | $255.0M | $267.7M |
| Payment Of Dividends To Shareholders | $378.3M | $376.5M | $358.3M | $333.3M | $285.2M | $112.5M | $0.00 | $0.00 |
| Provision For Other Credit Losses | -$295.8M | $732.5M | $560.7M | $904.2M | $452.8M | $230.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gain Loss On Derivative Instruments Net Pretax | $4.0M | -$2.0M | -$1.0M | $3.0M | $0.00 | $0.00 | -$8.7M | -$700.0K | $7.1M | $25.8M | $71.8M | $0.00 | -$17.0M | -$1.9M | -$2.6M | -$7.1M | $647.0K | -$33.4M | -$13.5M | -$39.4M |
| Costs And Expenses | $182.1M | $368.9M | $34.1M | -$170.4M | $267.6M | $641.8M | $384.9M | $289.4M | $205.0M | $381.3M | $158.2M | $342.3M | $282.7M | -$190.0M | $343.7M | $27.8M | $101.6M | $139.4M | -$68.2M | $129.7M |
| Noncontrolling Interest Increase From Contributions | $1.2M | $5.3M | $2.3M | $2.2M | $2.1M | $2.4M | $2.9M | $2.1M | $4.7M | $3.0M | $2.9M | $3.3M | $6.0M | $11.5M | $3.3M | $2.1M | $6.7M | $1.44B | ||
| Investment Income Net | $23.4M | $25.7M | $16.7M | $14.0M | $10.9M | $9.5M | $12.3M | $14.0M | $16.6M | $1.6M | $2.7M | $2.9M | $4.6M | $4.5M | ||||||
| Interest Paid Net | $138.8M | $79.0M | $82.6M | $86.2M | $64.5M | $51.1M | ||||||||||||||
| Payment Of Dividends To Shareholders | $95.4M | $93.8M | $88.6M | $82.3M | $66.0M | $0.00 | ||||||||||||||
| Provision For Other Credit Losses | $12.1M | -$203.9M | -$127.1M | -$227.6M | $212.4M | $583.6M | $277.1M | $241.2M | $118.8M | $305.1M | $105.7M | $184.6M | $137.8M | -$243.8M |
Most recent annual filing with the SEC: February 11, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.